Status:
COMPLETED
Buprenorphine Pharmacology Related to Addiction Treatment - 21
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Vermont
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
0+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000239
Last Update
August 17 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Treatment Research Center
Burlington, Vermont, United States, 05401